Sign in

CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
841966887
Phone
(888) 378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
  1. 4 Open-market buy Director bought 600,000 shares at $13.50 ($8,100,000)
  2. 4 Open-market buy Director bought 1,296,296 shares at $13.50 ($17,499,996)
  3. 4 Option exercise Chief Medical Officer acquired 6,349 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Option exercise Chief Medical Officer acquired 6,348 shares (option exercise)
  15. 4 Planned sale CFO and Secretary sold 10,757 shares at an average $9.10 ($97,864)
  16. 4 Option exercise Chief Medical Officer acquired 11,367 shares (option exercise)
  17. 4 Planned sale Chief Executive Officer sold 18,333 shares at $9.06 ($166,082)
  18. 4 Derivatives Options or other derivatives
  19. 4 Option exercise Chief Medical Officer acquired 5,017 shares (option exercise)
  20. 4 Planned sale Chief Medical Officer sold 5,026 shares at $15.00 ($75,398)

Page 5 of 9 · 180 filings